Possibilities of acute respiratory viral infections treatment with herbal medicinal products in routine clinical practice


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article presents and analyzes the data of a large-scale German study on the possibilities and effectiveness of the use of phytotherapy for acute respiratory viral infections (ARVI) treatment in routine clinical practice. The study included over 1 million patients who consulted general practitioners, pediatricians, and ENT doctors for acute upper and lower respiratory tract infections between January 1, 2015 and March 31, 2019. The results of the study allow us to conclude that the rational prescription of certain herbal remedies for ARVI treatment can significantly reduce the need for prescribing antibiotics in the further course of the disease, as well as reduce the duration of temporary disability of patients.

Full Text

Restricted Access

About the authors

Andrei G. Malyavin

A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russia

Email: maliavin@mail.ru
MD, professor, professor of the Department of phthisiology and pulmonology of the faculty of general medicine

References

  1. Martin D., Konrad M., Adarkwah C.C., Kostev K. Reduced antibiotic use after initial treatment of acute respiratory infections with phytopharmaceuticals - a retrospective cohort study. Postgrad Med. 2020; 132(5): 412-18. doi: 10.1080/00325481.2020.1751497.
  2. Kordt M. DAK-Gesundheit. DAK-Gesundheitsreport 2015. Available at: http://www.dak.de/dak/download/Vollstaendiger_bundesweiter_Gesundheitsreport_2015-1585948.pdf (date of access - 01.12.2021) (In German).
  3. Gesundheitsberichterstattung des Bundes: Haufigste Diagnosen in Prozent der Behandlungsfalle in Arztpraxen in Nordrhein (Rang und Anteil). Gliederungsmerkmale: Jahre, Nordrhein, Geschlecht, ICD10, Arztgruppe. Available at: www.gbe-bund.de (date of access - 01.12.2021) (In German).
  4. Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека. Сведения об инфекционных и паразитарных заболеваниях за январь-декабрь 2018 г. Доступ: https://www.rospotrebnadzor.ru/activities/statistical-materials/ statictic_details.php?ELEMENT_ID=11277 (дата обращения - 01.12.2021).
  5. ГБУ НИИОЗММ ДЗМ. Форма № 16-ВН. Сведения о причинах временной нетрудоспособности за 2019 г. Доступ: https://niioz.ru/upload/iblock/4b1/4b1f7ac338f11e4eb41883b38f9deea5.pdf (дата обращения - 01.12.2021).
  6. Coenen S., Francis N., Kelly M. et al. Are patient views about antibiotics related to clinician perceptions, management and outcome? A multi-country study in outpatients with acute cough. PLoS One. 2013; 8(10): e76691. doi: 10.1371/journal.pone.0076691.
  7. O'Connor R., O'Doherty J., O'Regan A. et al. Medical management of acute upper respiratory infections in an urban primary care out-of- hours facility: cross-sectional study of patient presentations and expectations. BMJ Open. 2019; 9(2): e025396. doi: 10.1136/ bmjopen-2018-025396.
  8. Zweigner J., Meyer E., Gastmeier P., Schwab F. Rate of antibiotic prescriptions in German outpatient care - are the guidelines followed or are they still exceeded? GMS Hyg Infect Control. 2018; 13: Doc04. doi: 10.3205/dgkh000310.
  9. Ostermaier A., Barth N., Schneider A. et al. On the edges of medicine - a qualitative study on the function of complementary, alternative, and non-specific therapies in handling therapeutically indeterminate situations. BMC Fam Pract. 2019; 20(1): 55. doi: 10.1186/s12875-019-0945-4.
  10. Клинические рекомендации. Острый тонзиллит и фарингит (острый тонзиллофарингит). Национальная медицинская ассоциация оториноларингологов, Межрегиональная общественная организация «Альянс клинических химиотерапевтов и микробиологов», Союз педиатров России, Межрегиональная ассоциация по клинической микробиологии и антимикробной химиотерапии, Международная общественная организация «Евро-Азиатское общество по инфекционным болезням». 2021. ID: 306. Доступ: https://cr.minzdrav.gov.ru/schema/306_2 (дата обращения - 01.12.2021).
  11. Клинические рекомендации. Острый синусит. Национальная медицинская ассоциация оториноларингологов. 2021. ID: 313. Доступ: https://cr.minzdrav.gov.ru/schema/313_2 (дата обращения - 01.12.2021).
  12. Клинические рекомендации. Бронхит. Возрастная категория: дети. Союз педиатров России, Межрегиональная ассоциация по клинической микробиологии и антимикробной химиотерапии, Российское респираторное общество. 2021. ID: 381. Доступ: https://cr.minzdrav.gov.ru/recomend/381_2 (дата обращения - 01.12.2021).
  13. Kraus E.M., Pelzl S., Szecsenyi J. et al. Antibiotic prescribing for acute lower respiratory tract infections (LRTI) - guideline adherence in the German primary care setting: An analysis of routine data. PLoS One. 2017; 12(3): e0174584. doi: 10.1371/journal.pone.0174584.
  14. Linde K., Atmann O., Meer K. et al. How often do general practitioners use placebos and non-specific interventions? Systematic review and meta-analysis of surveys. PLoS One. 2018; 13(8): e0202211. doi: 10.1371/journal.pone.0202211.
  15. Batzing-Feigenbaum J., Schulz M., Schulz M. et al. Outpatient antibiotic prescription: A population-based study on regional age-related use of cephalosporins and fluoroquinolones in Germany. Dtsch Arztebl Int. 2016; 113(26): 454-59. doi: 10.3238/arztebl.2016.0454.
  16. Salm F., Kramer T., Gastmeier P. Hausarzte mussen das Thema Antibiotika-Resistenzen angehen. MMW Fortschr Med. 2017; 159: 64-67 (In German).
  17. Richter-Kuhlmann E. Kampf gegen Antibiotikaresistenzen: Global und interdisziplinar. Dtsch Arztebl. 2017; 114(5): A-210/B-190/ C-190 (In German).
  18. Matthys H., Lehmacher W., Zimmermann A. et al. EPs 7630 in acute respiratory tract infections - a systematic review and metaanalysis of randomized clinical trials. J. Lung Pulm Respir Res. 2016; 3(1): 415.
  19. Mousa H.A. Prevention and treatment of influenza, influenza-like illness, and common cold by herbal, complementary, and natural therapies. J. Evid Based Complementary Altern Med. 2017; 22 (1): 166-74. doi: 10.1177/2156587216641831.
  20. Jund R., Mondigler M., Stammer H. et al. Herbal drug BNO 1016 is safe and effective in the treatment of acute viral rhinosinusitis. Acta Otolaryngol. 2015; 135(1): 42-50. doi: 10.3109/00016489.2014.952047.
  21. Anheyer D., Cramer H., Lauche R. et al. Herbal medicine in children with respiratory tract infection: Systematic review and metaanalysis. Acad Pediatr. 2018; 18(1): 8-19. doi: 10.1016/j.acap.2017.06.006.
  22. Griffin A.S., Cabot P., Wallwork B. et al. Alternative therapies for chronic rhinosinusitis: A review. Ear Nose Throat J. 2018; 97(3): E25-E33.
  23. Baars E.W., Zoen E.B., Breitkreuz T. et al. The contribution of complementary and alternative medicine to reduce antibiotic use: A narrative review of health concepts, prevention, and treatment strategies. Evid Based Complement Alternat Med. 2019; 2019: 5365608. doi: 10.1155/2019/5365608.
  24. Lum E.P.M., Page K., Whitty J.A. et al. Antibiotic prescribing in primary healthcare: Dominant factors and trade-offs in decisionmaking. Infect Dis Health. 2018; 23(2): 74-86. doi: 10.1016/j.idh.2017.12.002.
  25. Salm F., Schneider S., Schmucker K. et al.; RAI-Study Group. Antibiotic prescribing behavior among general practitioners - a questionnaire-based study in Germany. BMC Infect Dis. 2018; 18(1): 208. doi: 10.1186/s12879-018-3120-y.
  26. Rathmann W., Bongaerts B., Carius H.J. et al. Basic characteristics and representativeness of the German disease analyzer database. Int J. Clin Pharmacol Ther. 2018; 56(10): 459-66. doi: 10.5414/CP203320.
  27. Kemmerich B., Eberhardt R., Stammer H. Efficacy and tolerability of a fluid extract combination of Thyme herb and Ive leaves and matched placebo in adults suffering from acute bronchitis with productive cough. Arzneimittelforschung. 2006; 56(9): 652-60. doi: 10.1055/s-0031-1296767.
  28. Kemmerich B. Evaluation of efficacy and tolerability of a fixed combination of dry extracts of thyme herb and primrose root in adults suffering from acute bronchitis with productive cough. A prospective, double-blind, placebo-controlled multicentre clinical trial. Arzneimittelforschung. 2007; 57(9): 607-15. doi: 10.1055/s-0031-1296656.
  29. Ismail С., Willer G., Steindl H. [Bronchipret in cases of acute bronchitis]. Schweiz Zschr GanzheitsMedizin. 2003; 15: 171-175 (In German).
  30. Намазова-Баранова Л.С., Котлярова М.С., Ровенская Ю.В. с соавт. Сравнение эффективности и безопасности фито- и антибио-тикотерапии при лечении острого бронхита у детей: результаты многоцентрового двойного слепого рандомизированного клинического исследования. Педиатрическая фармакология. 2014; 5: 22-29. [Namazova-Baranova L.S., Kotlyarova M.S., Rovenskaya Yu.V. et al. Comparative analysis of effectiveness and safety of phyto- and antibiotic therapy of acute bronchitis in children: results of a multicenter double blind randomized clinical trial. Pediatricheskaya farmakologiya = Pediatric Pharmacology. 2014; 5: 22-29 (In Russ.)]. https://doi.org/10.15690/pf.v11i5.1161.
  31. Marzian O. [Treatment of acute bronchitis in children and adolescents. Non-interventional postmarketing surveillance study confirms the benefit and safety of a syrup made of extracts from thyme and ivy leaves]. MW Fortschr Med. 2007; 149(27-28 Suppl): 69-74 (In German).
  32. Сафина А.И. Лечение кашля при острых респираторных инфекциях у часто болеющих детей. Вопросы современной педиатрии. 2014; 1: 180-183. [Safina A. Treatment of cough in frequently ill children with acute respiratory tract infections. Voprosy sovremennoy pediatrii = Current Pediatrics. 2014; 1: 180-183 (In Russ.)]. https://doi.org/10.15690/vsp.v13i1.932.
  33. Руженцова Т.А., Будаковская А.В., Горелов А.В. Фитотерапия в лечении острых респираторных инфекций у детей. РМЖ. 2014; 21: 1538-1540.
  34. Нисевич Л., Намазова Л., Волков К. с соавт. Всегда ли необходимы антибиотики для лечения затяжного кашля у детей? Педиатрическая фармакология. 2008; 3: 64-71.
  35. Дрынов ГИ. Опыт профилактики и терапии респираторно-вирусных инфекций у больных с аллергическими заболеваниями. РМЖ. 2011; 23: 1426-1428.
  36. Tariq S., Wani S., Rasool W. et al. A comprehensive review of the antibacterial, antifungal and antiviral potential of essential oils and their chemical constituents against drug-resistant microbial pathogens. Microb Pathog. 2019; 134: 103580. doi: 10.1016/j. micpath.2019.103580.
  37. Roth M., Fang L., Stolz D., Tamm M. Pelargonium sidoides radix extract EPs 7630 reduces rhinovirus infection through modulation of viral binding proteins on human bronchial epithelial cells. PLoS One. 2019; 14(2): e0210702. doi: 10.1371/journal.pone.0210702.
  38. Glatthaar-Saalmuller B., Rauchhaus U., Rode S. et al. Antiviral activity in vitro of two preparations of the herbal medicinal product Sinupret® against viruses causing respiratory infections. Phytomedicine. 2011; 19 (1): 1-7. doi: 10.1016/j.phymed.2011.10.010.
  39. Seibel J., Kryshen K., Pongracz J.E. et al. In vivo and in vitro investigation of anti-inflammatory and mucus-regulatory activities of a fixed combination of thyme and primula extracts. Pulm Pharmacol Ther. 2018; 51: 10-17. doi: 10.1016/j.pupt.2018.04.009.
  40. Fokkens W.J., Lund V.J., Hopkins C. et al. European Position Paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020; 58(Suppl S29): 1-464. doi: 10.4193/Rhin20.600.
  41. Petursson P. GPs' reasons for «non-pharmacological» prescribing of antibiotics A phenomenological study. Scand J. Prim Health Care. 2005; 23(2): 120-25. doi: 10.1080/02813430510018491.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2021 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies